Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy

被引:69
作者
Rocha-Singh, KJ
Ahuja, RK
Sung, CH
Rutherford, J
机构
[1] St Johns Hosp, Prairie Heart Inst, Vasc Med Program, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Cardiol, Prairie Educ & Res Cooperat, Springfield, IL USA
[3] Univ Illinois, Dept Math Sci, Springfield, IL USA
关键词
ischemic nephropathy; renal failure; stents;
D O I
10.1002/ccd.10296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We assessed the long-term effect of successful renal artery stent revascularization on renal function, blood pressure control, and survival in patients with progressive renal dysfunction due to ischemic nephropathy. Ischemic nephropathy presents a potentially serious risk of complete loss of renal function. Surgical renal revascularization is associated with significant risk of mortality/morbidity in this patient population. The potential role and long-term effect of renal artery stent revascularization in this patient population is not well defined. A cohort of 51 patients (mean age, 72 years; 52.9% men) with progressive azotemia, defined as a preprocedure serum creatinine (Scr) value of greater than or equal to1.5 mg/dl and a negative slope of the reciprocal 1/Scr curve during the 12 months preceding revascularization, underwent successful primary stent deployment in 93 atherosclerotic renal artery lesions (42 bilateral, 9 solitary kidneys). Estimated glomerular filtration rate (EGFR) and serum creatinine values, blood pressure, antihypertensive medication requirements, and survival rates were monitored over a mean of 30-month follow-up. Renal artery duplex Doppler or renal angiography were performed at a mean of 13 months (range, 7-15 months) to assess stent patency. Stent implantation was successful in 92/93 (98.9%) stenotic renal arteries (mean preprocedure serum creatinine 2.3 +/- 0.9 mg/dl; range, 1.5-8.2 mg/dl). Forty-seven patients were eligible for 30-month follow-up of the procedural effect on renal function, blood pressure control, number of antihypertensive medications, and survival. At 1-year follow-up, the slope of the 1/Scr curve increased and the EGFR values significantly improved compared to preprocedure values (19.9 +/- 6.2 to 26.8 +/- 10.1 ml/min; P < 0.0001), serum creatinine decreased from the mean preprocedure value to 1.75 +/- 0.69 mg/dl (P < 0.001), with renal function improvement or stabilization observed in 94% of patients; three patients (7.3%) required permanent hemodialysis during the 30-month follow-up period. Systolic and diastolic blood pressure significantly decreased (from 177 +/- 28 to 148 +/- 25 mm Hg and from 92 +/- 15 to 78 +/- 14 mm Hg, respectively; P < 0.001) with fewer antihypertensive medications required to control blood pressure (3.5 +/- 0.9 vs. 1.9 +/- 1.3; P < 0.001). The patient survival rate after 30-month follow-up was 87%, with three deaths related to end-stage renal failure. Renal artery stent revascularization reversed progressive renal dysfunction within the first 12 months and maintained the improved level of renal function at 30-month follow-up while improving blood pressure control and reducing the number of antihypertensive medication requirements. Renal stent revascularization should be considered a valid therapeutic option for the long-term treatment of ischemic nephropathy.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 31 条
[21]  
Rocha-Singh KJ, 1999, CATHETER CARDIO INTE, V47, P167, DOI 10.1002/(SICI)1522-726X(199906)47:2<167::AID-CCD7>3.0.CO
[22]  
2-R
[23]   INACCURACY OF ESTIMATED CREATININE CLEARANCE FOR PREDICTION OF IOTHALAMATE GLOMERULAR-FILTRATION RATE [J].
ROLIN, HA ;
HALL, PM ;
WEI, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1984, 4 (01) :48-54
[24]  
Rosenfield K, 2000, CIRCULATION, V102, P825
[25]   Salvage of the solitary kidney by insertion of a renal artery stent [J].
Shannon, HM ;
Gillespie, IN ;
Moss, JG .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (01) :217-222
[26]  
SOS TA, 1991, CIRCULATION, V83, P162
[27]   DUPLEX ULTRASOUND SCANNING IN THE DIAGNOSIS OF RENAL-ARTERY STENOSIS - A PROSPECTIVE EVALUATION [J].
TAYLOR, DC ;
KETTLER, MD ;
MONETA, GL ;
KOHLER, TR ;
KAZMERS, A ;
BEACH, KW ;
STRANDNESS, DE .
JOURNAL OF VASCULAR SURGERY, 1988, 7 (02) :363-369
[28]   Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial [J].
van de Ven, PJG ;
Kaatee, R ;
Beutler, JJ ;
Beek, FJA ;
Woittiez, AJJ ;
Buskens, E ;
Koomans, HA ;
Mali, WPT .
LANCET, 1999, 353 (9149) :282-286
[29]   Long-term outcome of surgical revascularization in ischemic nephropathy: normalization of average decline in renal function [J].
van Rooden, CJ ;
van Bockel, JH ;
De Backer, GG ;
Hermans, J ;
Chang, PC .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (06) :1037-1049
[30]   Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease [J].
Watson, PS ;
Hadjipetrou, P ;
Cox, SV ;
Piemonte, TC ;
Eisenhauer, AC .
CIRCULATION, 2000, 102 (14) :1671-1677